Chronic graft rejection, characterized by a gradual occlusion of grafted vessels, is the most serious complication following heart and kidney transplantation. Although often associated with chronic production of anti-HLA and anti-endothelial antibodies, the precise role of antibodies in chronic rejection remains uncertain. Here we have investigated whether HLA-specific antibodies, either monoclonal or derived from patients, cause endothelial cell activation. Thus we investigated tyrosine phosphorlyation, NF-κB activation and cell proliferation in human umbilical vein endothelial cells ( 
Introduction
It is well established that the presence of HLA antibodies following heart or kidney transplantation (5,6). Both diseases have been associated with a chronic production of alloreactive with donor HLA antigens prior to renal or heart transplantation is associated with increased graft failure, antibodies (7-10), but the precise role of these antibodies has remained elusive. The demonstration that mAb against often in the form of hyperacute rejection (1-3). Traditionally, antibodies are detected using a complement-dependent cytomonomorphic MHC class I determinants induce endothelial cells to produce fibroblast growth factor receptors and protoxicity assay. It is therefore assumed that these antibodies act by fixing complement components leading to lysis and liferate in vitro (11) suggests anti-HLA antibodies may be activating endothelial cells in vivo. It is known that activated death of the target cells in vivo. Human endothelial cells constitutively express MHC class I and class II molecules (4), endothelial cells can produce a number of cytokines, chemokines and growth factors (12, 13) which could conceivably and are likely to be the first donor cells to be affected by antibody responses. In recent years it has become apparent promote the intimal proliferation seen in transplant-associated graft occlusive disease. That MHC molecules can act as that antibodies may be acting in a more subtle way to damage endothelial cells. Chronic rejection of solid organ transplants, signal transducers has been previously demonstrated in human T and B cells, where it was shown that ligation of MHC characterized by a progressive occlusive vasculopathy in donor grafts, is the most common long-term complication class I molecules resulted in tyrosine kinase activity (14, 15) .
The objective of this study, therefore, was to determine were washed in serum-free M199 and then incubated with 5% FCS for 18 h in order to minimize activation by serum. whether HLA antibodies, produced by patients, against specific HLA molecules induce signal transduction events Immediately prior to use the medium was removed and the cells washed once in serum-free M199 before being incubated within human umbilical vein endothelial cells (HUVEC) and human cardiac microvascular endothelial cells (CMEC). The in 2 ml M199 with 5% FCS. mAb were diluted to~50 µg/ml in 199 culture medium. Patients' IgG samples were diluted to end-point chosen was activation of the transcription factor, NF-κB, since this is a key transcription factor involved in 200 µg/ml. Confluent monolayers of HUVEC or CMEC were treated with media, mAb or patient samples for 30 min, activation of a number of different 'pro-inflammatory' genes (16) .
washed and treated with media, rabbit anti-mouse Ig mAb (RAM; Z0259 from Dako, Cambridge, UK) or rabbit antihuman Ig mAb (RAH; A0107 from Dako) for a further 30 min.
Methods
Positive controls were incubated with 100 U/ml of recombinant tumor necrosis factor (TNF)-α (Genzyme, West Malling, UK) Cell culture for 30 min. HUVEC were isolated as described previously (17) . CMEC, from adult human heart, were isolated and cultured as Tyrosine phosphorylation and IκB determination described by McDouall et al. (18) . All cells were maintained Treated endothelial cells were harvested and lysed into 1% in M199 culture medium with 2 mM L-glutamine (Gibco, SDS buffer for global tyrosine phosphorylation determination Paisley, UK), 150 U/ml penicillin/streptomycin (Gibco), 20%
by SDS-PAGE and Western blotting. Then 25 µg of total cell FCS (Sigma, Poole, UK) and 10 ng/ml heparinized endothelial lysates was loaded onto 12% acrylamide gels and resolved cell growth factor (Boehringer Mannheim, Lewes, UK) on by SDS-PAGE at 60 mA for 1.5 h. The proteins were then gelatin-coated tissue culture flasks. Confluent monolayers of transferred onto nitrocellulose membranes by Western blotsingle isolates between passages 4 and 6 were used for all ting. Blots were probed with an anti-phosphotyrosine antibody experiments.
(Upstate Biotechnology, New York, NY). This was then incub-HLA typing of endothelial cells ated with a horseradish peroxidase-conjugated RAM mAb (P0260 from Dako, Cambridge, UK). The blots were then HUVEC and CMEC were HLA typed by one of two methods. treated with ECL reagents (Amersham, Little Chalfont, UK) (i) Using lymphocytes isolated from cord blood or peripheral and visualized by exposure to autoradiography film blood in a standard microcytotoxicity assay using well-charac-(Amersham). For IκB-α, 25 µg of cytosolic extracts was loaded terized antisera. (ii) By PCR-SSP techniques for HLA-A and onto gels and blotted onto nitrocellulose membranes. Blots HLA-B (19) alleles using DNA extracted from umbilical cord were probed with a rabbit anti-IκB-α antibody (Santa Cruz; blood or peripheral blood.
from Insight Biotechnology, London, UK), followed by a goat Serum samples and antibodies anti-rabbit Ig antibody (Jackson, from Stratech, Luton, UK) and visualized as described above. Serum samples were collected from a number of patients who had previously undergone human aortic valve replacement Electrophoretic mobility shift assay for determination of NF-κB surgery and who had been shown to have produced HLABetween 1 and 5 µg of nuclear extract was incubated specific antibodies (20) . Their sera was investigated for with 0.175 pmol [α-32 P]dCTP-labelled oligodeoxynucleotides lymphocytotoxic activity using a panel of HLA-A, -B and -DR complementary to the consensus sequence of the NF-κB typed lymphocytes from 40 healthy volunteers and 20 patients DNA binding sites (Promega, Southampton UK), in a reaction with chronic lymphocytic leukemia (CLL) using a microcytotoxmix which also contained 10 mM Tris-HCl, pH 7.5, 20 mM icity technique previously described (21) . Sera were selected NaCl, 1 mM EDTA, 5% glycerol, 1.5 pmol irrelevant oligodeoxywhich demonstrated activity against HLA class I antigens, nucleotide and 2.5 ng poly(dI-dC) in a final reaction volume these sera did not have activity for MHC class II antigens as of 20 µl. Following incubation at room temperature for 1 h, determined by the cytotoxicity assay or subsequent screening samples were loaded onto prerun 6% native polyacrylamide by ELISA for class II antigens (Lambda Antigen Tray ELISA gels. Gels were fixed for 5 min and exposed to phosphoimage from One Lambda, VH Bio, Newcastle, UK). Non-HLA antibodscreens (Kodak, Rochester, NY) for at least 3 h. The screens ies were defined as sera showing IgM cytotoxic activity for were then visualized using a Storm 860 phosphoimage anaall peripheral blood lymphocytes but negative for reactivity lyser (Molecular Dynamics, Sunnyvale, CA) and intensity of with CLL and negative in the ELISA for class I and class II the bands measured using Image Quant software (Molecular antigens (Lambda antigen Tray ELISA as above). IgG antiDynamics) as arbitrary units. NF-κB activation was measured bodies were purified from patient serum samples using HiTrap as the amount of binding to the 32 P-labelled complementary protein G columns (Pharmacia) as previously described (22) . oligodeoxynucleotide corresponding to the consensus A small panel of mAb was also used for this study. These sequence of the NF-κB binding site in experiments and were W6/32 (anti-HLA class I), CR11-351 (anti-HLA-A2, 28) controls. The intensity of bands of experiments were comand 205-116 (anti-HLA-B13,27, provided by Dr K Gelsthorpe, pared to band intensity of controls (cells treated with RAM or Sheffield UK).
RAH alone) and results expressed as mean percentage Treatment of endothelial cells increase binding in experiments compared to controls. TNF-α was used as positive control since it has been shown to up-HUVEC or CMEC were plated onto 9 cm gelatin-coated dishes and allowed to become confluent. Once confluent, the cells regulate NF-κB (23).
Proliferation assays NF-κB consensus sequence compared to media controls. However, when these antibodies were cross-linked on the HUVEC were plated out into 96-well tissue culture plates at surface of CMEC the increase in NF-κB binding was 277% a concentration of 1ϫ10 4 cells/well in M199 and 5% FCS, but for CR11-351 and 170% for 205-116 (data not shown). did not contain endothelial cell growth factor, and incubated Eight patient IgG samples were used in experiments to overnight at 37°C. The next day, mAb, controls or allospecific determine whether allospecific HLA antibodies were capable serum samples were added to the cultures with at least 5 of NF-κB activation. Four of these samples were used against replicates for each treatment. HLA-A1, 2) and CM (anti-HLA-B44), and those with HLA nonspecific cells were WA (anti-HLA-A3), PS (anti-HLA-B44), MM Statistics (anti-HLA-A10, B8) and SH (anti-HLA-A2) (see Table 1 ). In Comparison of means were calculated using Student's t-test.
addition NHS (diluted to 5%) was also used in three separate P Ͻ 0.05 was considered to be statistically significant.
experiments. The samples (BR, KD, CM and VS) incubated with HLA-specific endothelial cells induced increased binding of NF-κB ranging from 27 to 186% compared to controls and Results 47% to 198% when these antibodies were cross-linked ( Table  Tyrosine phosphorylation 1). In contrast, when HLA-specific anti-sera (WA, PS, MM and SH) was incubated with HUVEC bearing irrelevant antigens Incubation of HUVEC for 30 min with W6/32 (which binds to there was no increase in NF-κB binding (range -25 to monomorphic determinants of MHC class I) had no effect -9%). Similarly, NHS did not result in an increase in binding on its own but additional cross-linking with RAM-induced compared to controls (range -36 to 13%). increased tyrosine phosphorylation of protein or proteins of
The results of four separate experiments are shown in Figs 75-80 and 200 kDa (Fig. 1, n ϭ 4) . Increased tyrosine 4 and 5. Enhanced NF-κB binding resulted from incubating phosphorylation of proteins of similar size was also seen after HUVEC bearing A2 antigens with IgG containing anti-A2 cross-linking PA2.6 mAb (also directed against HLA class I) antibodies (Fig. 4a) or CMEC bearing A1 antigens with (data not shown).
IgG containing anti-A1 antibodies (Fig. 4b) . However, IgG NF-κB transcription factor activity containing anti-A2 antibodies did not enhance NF-κB binding by HUVEC expressing A1 antigens (Fig. 4d ) and normal Effect of mAb directed against monomorphic class I determinserum did not enhance NF-κB binding compared to RAH ants. In these experiments, both CMEC and HUVEC were alone (Fig. 4c ). used as target cells; they behaved the same as far as response to antibodies was concerned. Incubation of CMEC Effect of HLA antibodies on IκB-α levels in endothelial cells. for 30 min with W6/32 alone resulted in a 74.4% increase NF-κB is normally found, bound to one of its inhibitors, IκB, binding of NF-κB compared to controls (CMEC treated with in the cytosol. Upon receipt of an appropriate signal, IκB RAM alone, P ϭ 0.001, n ϭ 7). However, addition of the becomes phosphorylated and releases NF-κB which transcross-linking antibody (RAM) resulted in a further increase in locates into the nucleus and binds to its specific site in the NF-κB binding of 94% above controls in the same seven promoter region of numerous genes. The phosphorylated experiments P ϭ 0.003 (Fig. 2 A and B) . Similarly, W6/32
IκB rapidly becomes ubiquinated and degraded. Therefore, alone caused a 52.5% increase in NF-κB binding (P ϭ 0.001) following NF-κB activation a decrease in the level of IκB in HUVEC and cross-linking W6/32 on the surface of HUVEC should also be observed. Incubation of HUVEC with W6/32, caused a 74.1% increase in NF-κB activity above control W6/32 plus RAM and TNF-α were able to cause a decrease (RAM)-treated cells (P ϭ 0.001, n ϭ 7) (Fig. 3) . In a single in the level of IκB-α, at 30 min, as determined by SDS-PAGE experiment the mAb PA2.6, which is also directed against and Western blotting (Fig. 6, lanes 3,4 and 9) . However, monomorphic determinants of HLA class I molecules, when patient samples (from BR and KD) that caused an increase cross-linked with RAM also resulted in increased NF-κB in NF-κB binding activity failed to reduce the level of IκB-α binding activity of 41% when compared to RAM-treated at the same time in the same experiments (Fig. 6, lanes 5-8) . CMEC alone. (24) . In order to discover whether antibodies directed against polymorphic epitopes can induce signalling, the HLAuptake at 24 h, ranging from 22 to 49% increased above control levels (P ϭ 0.015, data not shown). In five experiments, specific mAb CR11-351 (anti-HLA-A2) and 205-116 (anti-B13,27) were used on CMEC bearing the specific antigens sera from eight patients containing allospecific antibodies was added to HLA-specific endothelial cells and cell proliferation (n ϭ 2). The HLA-specific mAb CR11-351 and 205-116 resulted in 58 and 34% increase in NF-κB binding to the measured at 24 h (Table 2 , sera 1-15). This treatment signific- 4) , and W6/32 (lanes 5 and 6) and W6/32 followed by RAM (lanes 7 and 8) before being lysed and subjected SDS-PAGE (A). The peptides separated by electrophoresis were transferred to nitrocellulose and probed with mouse antiphosphotyrosine antibody. Binding of antibody was detected using peroxidase-conjugated rabbit anti-mouse Ig and visualized with ECL reagents. It can be seen from the scanning densitometry (B) data that proteins representing phosphorylated tyrosine residues have been induced by W6/32 and cross-linking antibody (lanes 7 and 8) of~75-80 and 200 kDa. In contrast, there was no increase in density of proteins of mol. wt 40 kDa, showing equal loading of lysates in all lanes. Representative experiment from four.
HUVEC proliferation
antly increased cell proliferation ranging from 23 to 106% in patients' sera; thus patients' sera containing irrelevant allospecific IgG HLA antibodies or sera containing IgM nonabove levels seen with NHS. This effect was not simply due to the presence of growth/survival promoting factors HLA antibodies incubated with endothelial cells ( whereby chronic production of antibodies could play a part in the pathogenesis of chronic rejection or transplant-associated coronary artery vasculopathy. Previous studies have shown that mAb against HLA class I monomorphic determinants (W6/32) are capable of causing activation of signal transduc- disease, the occlusion consisting of proliferating and migrating smooth muscle cells and myofibroblasts with deposition of extracellular matrix proteins (26) . Unlike conventional atheroma, the disease is characterized by diffuse and con-16-19) caused little or no cell proliferation, ranging from a reduction of -7 to 11% above controls seen with normal centric lesions which can affect the entire arterial tree and includes venous lesions, suggesting a pan-vascular disease serum. Cross-linking antibodies were not added in these experiments. The results of two individual experiments are (27). The endothelial cells are usually intact, unlike antibodymediated hyperacute rejection which is characterized by shown in Fig. 7 . Incubation of HLA-specific HUVEC with allospecific anti-sera (MD, BG, JD and SW) increased [ 3 H]thymicrovascular destruction (28, 29) . These features would be consistent with the hypothesis that chronic production of midine uptake (Fig. 7a) compared to normal serum controls. Use of allospecific antisera (nos 16 and 17) or sera containing antibodies against donor endothelial cells results in activation but not destruction of such cells. Chronic production of IgM non-HLA antibodies (nos 18 and 19) on irrelevant HUVEC had no effect on [ 3 H]thymidine uptake compared to normal anti-HLA antibodies (9,10) and anti-endothelial antibodies (30-32) has been reported in patients with transplant-associserum (Fig. 7b) . ated coronary artery disease. NF-κB is a family of nuclear transcription factors found in Discussion nearly all cell types that were first described as a dimer that bound to the enhancer of the Ig κ light chain (33). It normally This study has confirmed that antibodies against HLA determinants can activate endothelial cells, providing a mechanism exists in the cytoplasm in a dormant form bound to an inhibitory protein, IκB, of which several forms exist (IκB-α, uncovers nuclear localization signals on the Rel proteins, which results in the rapid translocation of NF-κB to the IκB-β, IκB-γ, IκB-ε) (34). IκB is activated by specific IκB kinases, and on phosphorylation it undergoes rapid ubiquitinnucleus. In the nucleus NF-κB binds to the consensus sites in the promoter sequence of the inducible genes ation and proteolysis by non-specific proteases (35). This (GGGACTTTCC), which results in rapid increase in transcrip-TNF-α), oxidants, viruses and activators of protein kinase C (36) . NF-κB may induce many 'inflammatory' genes that tion and increased protein synthesis. Many stimuli activate NF-κB including pro-inflammatory cytokines (e.g. IL-1 and encode for pro-inflammatory cytokines, chemokines that facil-itate transendothelial migration, inflammatory enzymes such proliferation are independent pathways initiated by signal transduction through MHC class I molecules. as inducible NO synthase, cyclooxygenase (Cox-2), adhesion molecules and cytokine receptors (such as IL-2 receptor). It When using W6/32 in our studies we were able to show that binding and cross-linking of W6/32 to endothelial cells is thus not possible to say precisely what are the biological consequences of antibody activation of endothelial cells;
led not only to NF-κB activation but also a reduction in IκB-α activity. However, when using allospecific antibodies from many of the above effects would be relevant for accelerating or promoting growth of intimal lesions. We do know that serum patient samples we were unable to show any decrease in IκB-α. Possible explanations for this persistence of IκB-α may from these patients (with aortic valve allografts) also contains IL-1 which can appear in the IgG fraction following separation be that inhibitors of NF-κB other than IκB-α, such as IκB-β, IκB-ε, IκB-γ or Bcl-3 may be involved in the inhibition of NFthrough Centricon filters (21) and causes up-regulation of adhesion molecules when the sera is incubated with human κB activation induced by human alloantibodies. Alternatively, there is evidence that the phosphorylation of a tyrosine residue endothelial cells (21) . These particular sera did not contain either IL-1 or TNF-α (measured by ELISA, data not shown) of IκB molecules, rather than serine residues as normally occurs, can lead to activation of NF-κB, but does not result and did not cause up-regulation of adhesion molecules. We are currently investigating effects down-stream of NF-κB in the degradation of the IκB molecules (41).
In conclusion, alloreactive HLA antibodies have the ability activation to understand further what are the biological consequences of antibody-mediated activation of endothelial to induce activation of endothelial cells indicated by increased signal transduction events and resulting in proliferation of cells.
HUVEC are commonly used as model endothelial cells in endothelial cells. Further studies to elucidate the molecules produced following the activation of signalling pathways may studies of vascular biology. Here we combined the use of HUVEC with adult microvascular endothelial cells derived help to understand the mechanisms involved in the rejection process following solid organ allografts. from human heart (18) . CMEC were used, because they are more physiological and also because we have previously reported that they are considerably more sensitive to activation Acknowledgements by IFN-γ than are HUVEC (37) . However, as yet, we have not This study was supported by the British Heart Foundation.
found any difference in sensitivity to HLA antibodies, using the measurements described in this paper.
The current results strongly suggest the antibody effect is Abbreviations mediated through antigen-specific binding and is not the endothelial cells (38) . Thus no effect was obtained using own, but this was usually enhanced by addition of secondary antibodies. This suggests that aggregation of HLA molecules (which would be achieved using mAb alone) is necessary for References signal transduction. Interestingly, the IgG separated from
